Editor's Note Clinicians managing surgical patients on direct oral anticoagulants (DOACs) should adopt a different approach depending on the procedure, according to research published August 12 in JAMA Network. Used to treat patients with atrial fibrillation and venous thromboembolism, DOACs must be managed effectively to minimize risks of bleeding, researchers…

Read More

Editor's Note A 13-year study at US Veterans Affairs (VA) medical centers found a decline in both hospital-associated infections (HAIs) and antimicrobial resistance for common pathogens, MedPage Today August 15 reports. From 2007 to 2019, the overall infection rate of nine pathogens decreased, with an average annual percentage change (AAPC)…

Read More

Editor's Note The “surgical pause”—a means of validating whether surgery is truly safe for patients deemed to be “frail” before starting a procedure—significantly reduces mortality rates and is changing practices at more than 50 Veterans Administration (VA) hospitals, the Pittsburgh Post-Gazette reported August 18. Developed by VA surgeons Daniel Hall…

Read More

Editor's Note Combining dexterity and cost-effectiveness, handheld robotic devices offer potential to bridge the gap between traditional laparoscopy and more expensive robotic platforms, researchers concluded August 8 in the journal Surgery. The mini-review of clinical trials covered clinical applications of three handheld robotic devices: the HandX powered laparoscopic instrument from…

Read More

Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events.   These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…

Read More

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

Editor's Note MD Anderson Cancer Center shared insights on overcoming OR capacity challenges during a session at last year’s OR Manager Conference that highlighted creative solutions to staffing shortages and capacity constraints. With the ongoing pressures exacerbated by COVID-19, which is hitting a peak this summer, MD Anderson has implemented…

Read More

Editor's Note Evidence is mounting for the use of antibiotics as a valid alternative to surgery for acute appendicitis, including in pediatric cases, the Washington Post reported August 17. The article details how this treatment—described as a “dark secret” by one expert testifying to its use in the 1950s, prior…

Read More

Editor's Note A post hoc analysis of the SCOT phase 3 randomized clinical trial reveals that initiating adjuvant chemotherapy more than 6 weeks after surgery is linked to worse disease-free survival (DFS) in patients with high-risk stage II and stage III colorectal cancer. Published June 12 in JAMA Surgery, the…

Read More

Editor's Note Planned Parenthood used the occasion of the Democratic National Convention in Chicago to offer free medication abortions and vasectomies at a mobile clinic, the Chicago Tribune reported August 19. According to the article, the group aims to demonstrate the possibilities of accessible reproductive healthcare when supported by favorable…

Read More